Institut des Sciences et Techniques, Bobo-Dioulasso — Malaria Vaccine Clinical Trial (Ouedraogo)

Organization:
Institut des Sciences et Techniques, Bobo-Dioulasso
Award Date:
08/2021
Amount:
$631,162
Purpose:
To participate in a phase III clinical trial of a malaria vaccine.

Open Philanthropy recommended a grant of $631,162 over three years to the Institut des Sciences et Techniques, Bobo-Dioulasso to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford. Dr. Jean Bosco Ouedraogo will serve as the Institut's principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the University Of Science Technical And Technologies De Bamako, the Institut de Recherche en Sciences de la Santé, the KEMRI Wellcome Trust Research Programme, and the Ifakara Health Institute.

This falls within Open Philanthropy's focus area of scientific research, specifically within its interest in advancing human health and wellbeing.

Read more: